Yu-Zhou Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yu-Zhou Wu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Wei Cui
3 shared publicationsJing-Chao Lu
2 shared publicationsLei Zhang
2 shared publicationsShu-Qin Li
2 shared publicationsShuqin Li
2 shared publicationsFengfei Wang
1 shared publication
Latest Publications
- 1 May 2010
- Vol. 26 (2) , 141-3
[Effects of pravastatin on the expression of transforming growth factor-beta 1 in cardiac fibroblasts].
- 1 May 2010
- Vol. 26 (2) , 141-3
[Effects of pravastatin on the expression of transforming growth factor-beta 1 in cardiac fibroblasts].
- 1 March 2008
- Published by Elsevier in Phytomedicine
- Vol. 15 (3) , 164-169
Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: Role of endothelium-dependent vasodilation
- 1 March 2008
- Published by Elsevier in Phytomedicine
- Vol. 15 (3) , 164-169
Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: Role of endothelium-dependent vasodilation
- 1 August 2007
- Vol. 23 (3) , 343-6
[Effects of pravastatin on the expression of endothelin induced by aldosterone in rat cardiac fibroblasts].
To investigate the effects of pravastatin on endothelin(ET) expression induced by aldosterone in cultured neonatal rat cardiac fibroblasts. ET concentration in conditioned medium was measured by radioimmunoassay, intracellular ET-1 level was evaluated by flow cytometry, and the expression of preproendothelin-1 (ppET-1) was detected and quantified using reverse transcriptase-polymerase chain reaction (RT-PCR) method. The cardiac fibroblasts, treated with aldosterone at 107 mol/L, significantly up-regulated ppET-1 mRNA expression, as well as ET-1 synthesis and release. Pravastatin (10(-5), 10(-4), 10(-3) mol/L) dose-dependently blocked these effects. In contrast, pravastatin-induced inhibitory effects were reversed in the presence of mevalonate. Pravastatin down-regulated ppET-1 mRNA expression, as well as ET-1 synthesis and release induced by aldosterone in a process specifically related to mevalonate in cardiac fibroblasts.
- 1 August 2007
- Vol. 23 (3) , 343-6
[Effects of pravastatin on the expression of endothelin induced by aldosterone in rat cardiac fibroblasts].
To investigate the effects of pravastatin on endothelin(ET) expression induced by aldosterone in cultured neonatal rat cardiac fibroblasts. ET concentration in conditioned medium was measured by radioimmunoassay, intracellular ET-1 level was evaluated by flow cytometry, and the expression of preproendothelin-1 (ppET-1) was detected and quantified using reverse transcriptase-polymerase chain reaction (RT-PCR) method. The cardiac fibroblasts, treated with aldosterone at 107 mol/L, significantly up-regulated ppET-1 mRNA expression, as well as ET-1 synthesis and release. Pravastatin (10(-5), 10(-4), 10(-3) mol/L) dose-dependently blocked these effects. In contrast, pravastatin-induced inhibitory effects were reversed in the presence of mevalonate. Pravastatin down-regulated ppET-1 mRNA expression, as well as ET-1 synthesis and release induced by aldosterone in a process specifically related to mevalonate in cardiac fibroblasts.